| ADP | adenosine diphosphate |
| Asm | acid sphingomyelinase |
| ATX | autotaxin |
| BFGF | basic fibroblast growth factor |
| CAF | cancer-associated fibroblast |
| CD | cluster differentiation |
| CDD | cytidine deaminase |
| CXCR4 | chemokine receptor type 4 |
| ECM | extracellular matrix |
| EGFR | epidermal growth factor receptor |
| EML4-ALK | echinoderm microtubule-associated protein-like 4-anaplastic lymphoma kinase |
| EMT | epithelial mesenchymal transition |
| EPCs | epithelial progenitor cells |
| fL | femtoliter |
| FLK-1 | fetal liver kinase-1 |
| GP | glycoprotein |
| hENT | human equilibrative transporter |
| HUVEC | human umbilical vein endothelial cell |
| JNK | c-Jun N-terminal kinases |
| LLC | Lewis lung carcinoma |
| LPA | lysophosphatidic acid |
| MHC | major histocompatibility complex |
| MMPs | matrix metalloproteinases |
| MPs | microparticles |
| MPV | mean platelet volume |
| NK | natural killer |
| NKG2D | natural killer group 2D |
| NPY | neuropeptide Y |
| P2Y12 | platelet ADP receptor |
| PAR-1 | protease-activated receptor-1 |
| PDGF | platelet-derived growth factor |
| PDGFR | platelet-derived growth factor receptor |
| PDW | platelet distribution width |
| (PG)E2 EP3 | prostaglandin E2 receptor subtype EP3 |
| RTK | receptor tyrosine kinase |
| SDF-1 | stromal cell-derived factor-1 |
| TBHS-1 | thrombospondin-1 |
| TCIPA | tumor cell-induced platelet activation |
| TFs | tissue factors |
| TGF-β | transforming growth factor-β |
| TKI | tyrosine kinase inhibitor |
| TX | thromboxane |
| VEGF | vascular endothelial growth factors |